Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Opiranserin is a development as an injectable agent for the treatment of postoperative pain. Opiranserin is a non-opioid and non-NSAID analgesic candidate and is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) (IC50s: 0.86 and 1.3 μM, respectively). Opiranserin displays antagonistic activity on rP2X3 (IC50=0.87 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Opiranserin is a development as an injectable agent for the treatment of postoperative pain. Opiranserin is a non-opioid and non-NSAID analgesic candidate and is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) (IC50s: 0.86 and 1.3 μM, respectively). Opiranserin displays antagonistic activity on rP2X3 (IC50=0.87 μM). |
Targets&IC50 | GlyT2:0.86 μM, 5-HT2A receptor:1.3 μM, P2X3 (rat):0.87 μM |
Molecular Weight | 394.51 |
Formula | C21H34N2O5 |
CAS No. | 1441000-45-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Opiranserin 1441000-45-8 GPCR/G Protein Membrane transporter/Ion channel Neuroscience 5-HT Receptor P2X Receptor GlyT Glycine transporters postoperative VVZ-149 Serotonin Receptor 5-hydroxytryptamine Receptor VVZ 149 pain Inhibitor non-opioid P2XRs anti-inflammatory VVZ149 analgesic inhibit inhibitor